Malaria: Towards a new treatment!;Paludisme: Vers un nouveau traitement!

Medecine/Sciences

Volumn 21, Issue 4, 2005, Pages 341-343

  Wein, Sharon ^a   Calas, Michèle ^a   Bressolle, Françoise ^b   Herrera, Socrates ^c   Thomas, Alan ^d   Vial, Henri ^a  

^a CNRS   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSIDAD DEL VALLE   (Colombia)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; CHOLINE KINASE; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; CHOLINEPHOSPHOTRANSFERASE; FANSIDAR; HEMOGLOBIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; QUININE; SPHINGOMYELIN;

ANOPHELES; HUMAN; MALARIA; NONHUMAN; NOTE; PLASMODIUM;

EID: 17444420746     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005214341     Document Type: Note

References (13)

1. Hartl DL. The origin of malaria: mixed messages from genetic diversity. Nat Rev Microbiol 2004; 2: 15-22.
2. http://www.who.int/tdr/diseases/malaria/default.htm
3. Biagini GA, O'Neill PM, Nzila A, et al. Antimalarial chemotherapy: young guns or back to the future? Trends Parasitol 2003; 19: 479-87.
4. Kremsner PG, Krishna S. Antimalarial combinations. Lancet 2004; 364: 285-94.
5. Vial HJ, Ben Mamoun C. Plasmodium lipids: metabolism and function. In: Sherman IW, ed. Molecular approach to malaria. Washington DC: ASM Press, 2005 (sous presse).
6. Roggero R, Zufferey R, Minca M, et al. Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae. Antimicrob Agents Chemother 2004; 48: 2816-24.
7. Calas M, Ancelin ML, Cordina G, et al. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts. J Med Chem 2000; 43: 505-16.
8. Wengelnik K, Vidal V, Ancelin ML, et al. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 2002; 295: 1311-4.
9. Ancelin ML, Calas M, Vidal-Sailhan V, et al. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother 2003; 47: 2590-7.
10. Ancelin ML, Calas M, Bonhoure A, et al. In vivo activities of mono and bis quarternary ammonium salts interfering with Plasmodium phospholipids metabolism. Antimicrob Agents Chemother 2003; 47: 2598-605.
11. Vial HJ, Wein S, Farenc C, et al. Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc Natl Acad Sci USA 2004; 101: 15458-63.
12. Biagini GA, Richier E, Bray P, et al. Heme binding contributes to the antimalarial activity of bisquaternary ammonium compound. Antimicrob Agents Chemother 2003; 47: 2584-9.
13. Van Dooren GG, Walker RF, Roos DS, Mc Fadden GI. Traffic jams: protein transport in Plasmodium falciparum. Parasitol Today 2000; 16: 421-7.